黄芩泻白散合黛蛤散加减治疗感染后咳嗽疗效观察  

Clinical Observation on Huangqin Xiebai San combined with Daige San in the treatment of Post Infection Cough

作　　者：李炬明 辛大永 

机构地区：[1]北京中医医院顺义医院呼吸科,北京101300

出　　处：《世界中医药》2016年第2期247-249,共3页World Chinese Medicine

基　　金：北京市顺义区级基金项目(编号:sy-201305)

摘　　要：目的:观察黄芩泻白散合黛蛤散加减治疗感染后咳嗽的临床疗效。方法:将120例感染后咳嗽肝咳证患者随机分为2组,每组60人。治疗组予黄芩泻白散合黛蛤散为基本方加减;对照组给予马来酸氯苯那敏片及可愈糖浆口服。2组疗程均为2周。比较治疗前后2组患者症候积分变化情况及临床总疗效。结果:治疗2周后,治疗组总有效率92.11%,明显高于对照组76.32%(P<0.05),且治疗组证候积分明显低于对照组(P<0.05)。结论:黄芩泻白散和黛蛤散加减治疗感染后咳嗽疗效显著。Objective： To observe the clinical effect of Huangqin Xiebai San and Daige San in the treatment of post infection cough. Methods： A total of 120 cases of patients with post infection cough were randomly divided into two groups,each group of60 people. The treatment group was treated by Huangqin Xiebai San and Daige San and the control group was treated by Chlorphenamine Maleate tablets and Codeine and Guaifenesin syrup. Both groups has been treating for 2weeks. Comparison the changes of symptoms and clinical efficacy of the two groups. Results： After 2 weeks of treatment,the total effective rate of the treatment group was 92. 11% and that of the control group was76. 32%（ P 〈 0. 05） The TCM score of the treatment group was significantly lower than that of the control group（ P 〈 0. 05）. Conclusion： Huangqin Xiebai San and Daige San is effective in treating infection cough.

关 键 词：感染后咳嗽 黄芩泻白散合黛蛤散加减 疗效观察 

分 类 号：R56[医药卫生—呼吸系统]